Literature DB >> 33065712

Incorporating Absolute Phagocyte Count With Absolute Neutrophil Count as a Measure for Safe Discharge for Pediatric Oncology Febrile Neutropenia: A Pilot Study.

Andrew Picca1, Amy E Wahlquist2, Michelle Hudspeth3.   

Abstract

Adequate bone marrow recovery is a discharge requirement after admission for febrile neutropenia in oncology patients, without specific threshold in consensus guidelines. In January 2016, our institution implemented count recovery criteria of absolute neutrophil count ≥100 cells/μL and absolute phagocyte count ≥300 cells/μL compared with prior criteria of absolute neutrophil count ≥500 cells/μL. Retrospective analysis comparing pre (July 2013 to December 2015, N=68) and post (January 2016 to June 2018, N=30) groups showed no difference in readmissions (P>0.9), no patient deaths, and decreased average length of stay in the post group (P<0.0001). Updated count recovery criteria seem feasible and safe.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33065712      PMCID: PMC8046833          DOI: 10.1097/MPH.0000000000001974

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.170


  10 in total

Review 1.  Management of fever in patients with cancer and treatment-induced neutropenia.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

2.  Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.

Authors:  Randy A Taplitz; Erin B Kennedy; Eric J Bow; Jennie Crews; Charise Gleason; Douglas K Hawley; Amelia A Langston; Loretta J Nastoupil; Michelle Rajotte; Kenneth Rolston; Lynne Strasfeld; Christopher R Flowers
Journal:  J Clin Oncol       Date:  2018-02-20       Impact factor: 44.544

3.  National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014.

Authors:  Anusha Lekshminarayanan; Parth Bhatt; Vijay Gandhi Linga; Riddhi Chaudhari; Brian Zhu; Mihir Dave; Keyur Donda; Sejal Savani; Samir V Patel; Zeenia C Billimoria; Smita Bhaskaran; Samer Zaid-Kaylani; Fredrick Dapaah-Siakwan; Neel S Bhatt
Journal:  J Pediatr       Date:  2018-07-17       Impact factor: 4.406

4.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

5.  Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.

Authors:  T C Griffin; G R Buchanan
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

6.  Healthcare utilization and spending by children with cancer on Medicaid.

Authors:  Emily L Mueller; Matt Hall; Jay G Berry; Aaron E Carroll; Michelle L Macy
Journal:  Pediatr Blood Cancer       Date:  2017-04-18       Impact factor: 3.167

Review 7.  Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.

Authors:  Thomas Lehrnbecher; Paula Robinson; Brian Fisher; Sarah Alexander; Roland A Ammann; Melissa Beauchemin; Fabianne Carlesse; Andreas H Groll; Gabrielle M Haeusler; Maria Santolaya; William J Steinbach; Elio Castagnola; Bonnie L Davis; L Lee Dupuis; Aditya H Gaur; Wim J E Tissing; Theo Zaoutis; Robert Phillips; Lillian Sung
Journal:  J Clin Oncol       Date:  2017-05-01       Impact factor: 44.544

8.  Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.

Authors:  Melanie A Villanueva; Keith J August
Journal:  Pediatr Blood Cancer       Date:  2016-05-19       Impact factor: 3.167

9.  Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.

Authors:  Matthew E Campbell; Debra L Friedman; Daniel E Dulek; Zhiguo Zhao; Yi Huang; Adam J Esbenshade
Journal:  Pediatr Blood Cancer       Date:  2017-11-08       Impact factor: 3.167

10.  Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.

Authors:  R O Bash; J A Katz; J V Cash; G R Buchanan
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.